FINNENCE. Open the feed →

News · ■ Unclear/unknown · 1 source confirmed · 2026-09-28 12:42 UTC

Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.

Why now

Thesis: GLP-1 vision-risk question adds safety overhang

Catalyst to watch: Further studies or regulator label action

Main risk: Link is suggestive, not established causation

Why it matters

GLP-1 drugs possibly linked to rare vision loss could add a safety concern for makers.

Details

Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.

Related assets & topics

Eli Lilly · LLYNovo Nordisk · NVOHealthcare

Sources

Related stories

More on the feed →

Explore the live feed → Search events